Applied Pharmaceutical Innovation is pleased to announce the appointment of Allan Aginsky to the position of Senior Manager, Strategic Projects. Allan brings a wealth of knowledge to the API team, with over 40 years of experience in the development and implementation of drug manufacturing projects. For the past 8 months Allan has served as the principal consultant driving the planning and build-out of API’s proposed pharmaceutical manufacturing facility and as the project progresses Allan has taken on a formal role with the team.
Allan’s career history includes positions at Abbott, Merck, and Genpharm, with roles such as plant manager, vice president production, and general manager. Since 2000 Allan has served as president and founder of API Partners, providing manufacturing site establishment and API sourcing. Allan has conducted quality audit and reviews at sites in over 24 countries, establishes many sites of pharmaceutical production spanning a wide range of drugs in the US, China, India, and Canada, all with USFDA/Health Canada/MHRA regulatory accreditation.
“We’re thrilled to have Allan join us in a direct role on the team,” says API CEO, Andrew MacIsaac, “Allan’s expertise and hard work has been instrumental to our manufacturing capacity project so far. Given he’s completed tech transfers on most of the drugs on the Health Canada shortage list, and designed and run manufacturing sites around the world I cannot think of anyone who could be more suited to moving this project forward quickly to meet the challenges of Covid-19.”
Allan has played a key role in developing, designing, and sourcing the planned 40,000 sqr foot facility that will be used to provide Canadian-based manufacturing of drugs facing shortages during the Covid-19 crisis and beyond as well as a critical capacity for Canadian innovators in bringing their discoveries to treatments here in Canada.